( in Million)
Particulars
Jun 2026
Mar 2026
Dec 2025
Sep 2025
Audited / UnAudited
UnAudited
UnAudited
UnAudited
UnAudited
Net Sales
103.29
98.56
102.01
120.74
Total Expenditure
96.26
97.29
96.52
114.54
PBIDT (Excl OI)
7.03
1.27
5.49
6.19
Other Income
1.07
5.46
2.84
2.73
Operating Profit
8.10
6.72
8.32
8.92
Exceptional Items
NA
NA
NA
NA
Depreciation
4.64
5.13
4.42
4.78
Profit Before Tax
-0.11
-0.21
0.91
0.29
Provisions and contingencies
NA
NA
NA
NA
Profit After Tax
-1.47
-1.32
-0.10
-0.46
Extraordinary Items
NA
NA
NA
NA
Prior Period Expenses
NA
NA
NA
NA
Other Adjustments
NA
NA
NA
NA
Net Profit
-1.47
7.79
-0.10
-0.46
Minority Interest
NA
-9.12
-2.1
1.29
Shares of Associates
8.53
7.2
1.65
Misc. Expenses Written off
NA
NA
NA
NA
Consolidated Net Profit
7.05
5.88
-0.54
0.84
Equity Capital
114
114
114
113.6
Face Value (IN RS)
10
10
10
10
Calculated EPS
0.61
0.51
-0.04
0.07
Calculated EPS (Annualised)
2.47
2.06
-0.18
0.29
Calculated Adj_EPS
0.61
0.51
-0.04
0.07
No of Public Share Holdings
6268901
4782912
5221840
4727334
% of Public Share Holdings
54.99
41.96
45.81
41.61
PBIDTM% (Excl OI)
6.80
1.28
5.38
5.13
PATM%
-1.43
-1.33
-0.09
-0.38